133 related articles for article (PubMed ID: 1899812)
1. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3.
Crespi CL; Penman BW; Steimel DT; Gelboin HV; Gonzalez FJ
Carcinogenesis; 1991 Feb; 12(2):355-9. PubMed ID: 1899812
[TBL] [Abstract][Full Text] [Related]
2. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6.
Crespi CL; Penman BW; Gelboin HV; Gonzalez FJ
Carcinogenesis; 1991 Jul; 12(7):1197-201. PubMed ID: 2070484
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
4. Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B1.
Crespi CL; Steimel DT; Aoyama T; Gelboin HV; Gonzalez FJ
Mol Carcinog; 1990; 3(1):5-8. PubMed ID: 2108694
[TBL] [Abstract][Full Text] [Related]
5. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
[TBL] [Abstract][Full Text] [Related]
6. Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b5 in the activation of aflatoxin B1.
Ueno Y; Ishii K; Omata Y; Kamataki T; Kato R
Carcinogenesis; 1983 Aug; 4(8):1071-3. PubMed ID: 6409444
[TBL] [Abstract][Full Text] [Related]
7. Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2.
Macé K; Gonzalez FJ; McConnell IR; Garner RC; Avanti O; Harris CC; Pfeifer AM
Mol Carcinog; 1994 Oct; 11(2):65-73. PubMed ID: 7916994
[TBL] [Abstract][Full Text] [Related]
8. Non-coplanar and coplanar polychlorinated biphenyls potentiate genotoxicity of aflatoxin B1 in a human hepatocyte line by enhancing CYP1A2 and CYP3A4 expression.
Chen Y; Liu Y
Environ Pollut; 2019 Mar; 246():945-954. PubMed ID: 31159144
[TBL] [Abstract][Full Text] [Related]
9. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
10. Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens.
Penman BW; Chen L; Gelboin HV; Gonzalez FJ; Crespi CL
Carcinogenesis; 1994 Sep; 15(9):1931-7. PubMed ID: 7923587
[TBL] [Abstract][Full Text] [Related]
11. Fetus-specific CYP3A7 and adult-specific CYP3A4 expressed in Chinese hamster CHL cells have similar capacity to activate carcinogenic mycotoxins.
Hashimoto H; Nakagawa T; Yokoi T; Sawada M; Itoh S; Kamataki T
Cancer Res; 1995 Feb; 55(4):787-91. PubMed ID: 7850790
[TBL] [Abstract][Full Text] [Related]
12. A NIH/3T3 cell line stably expressing human cytochrome P450-3A4 used in combination with a lacZ' shuttle vector to study mutagenicity.
De Groene EM; Seinen W; Horbach GJ
Eur J Pharmacol; 1995 May; 293(1):47-53. PubMed ID: 7545582
[TBL] [Abstract][Full Text] [Related]
13. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P3-450 cDNA encodes aflatoxin B1-4-hydroxylase.
Faletto MB; Koser PL; Battula N; Townsend GK; Maccubbin AE; Gelboin HV; Gurtoo HL
J Biol Chem; 1988 Sep; 263(25):12187-9. PubMed ID: 3137222
[TBL] [Abstract][Full Text] [Related]
15. Comparative aflatoxin B1 mutagenesis of Salmonella typhimurium TA 100 in metabolic and photoactivation systems.
Israel-Kalinsky H; Malca-Mor L; Stark AA
Cancer Res; 1984 May; 44(5):1831-9. PubMed ID: 6424931
[TBL] [Abstract][Full Text] [Related]
16. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1.
Kamdem LK; Meineke I; Gödtel-Armbrust U; Brockmöller J; Wojnowski L
Chem Res Toxicol; 2006 Apr; 19(4):577-86. PubMed ID: 16608170
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes.
Ueng YF; Shimada T; Yamazaki H; Guengerich FP
Chem Res Toxicol; 1995 Mar; 8(2):218-25. PubMed ID: 7766804
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and cytotoxicity of aflatoxin b1 in cytochrome p-450-expressing human lung cells.
Van Vleet TR; Klein PJ; Coulombe RA
J Toxicol Environ Health A; 2002 Jun; 65(12):853-67. PubMed ID: 12079611
[TBL] [Abstract][Full Text] [Related]
19. Cellular interactions and metabolism of aflatoxin: an update.
McLean M; Dutton MF
Pharmacol Ther; 1995 Feb; 65(2):163-92. PubMed ID: 7540767
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems.
Neal GE; Eaton DL; Judah DJ; Verma A
Toxicol Appl Pharmacol; 1998 Jul; 151(1):152-8. PubMed ID: 9705898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
